Paracetamol
Paracetamol is one of the most widely used drugs to reduce fever and mild pain
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
Paracetamol is an analgesic and antipyretic agent. It blocks the synthesis of prostaglandins in the central nervous system by inhibiting cyclooxygenase 1 and cyclooxygenase 2, affecting the centers of pain and thermoregulation. Does not show anti-inflammatory effect. The lack of influence on the synthesis of prostaglandins in peripheral tissues determines the absence of a negative effect on the water-salt metabolism (sodium and water retention) and the mucous membrane of the gastrointestinal tract.
Pharmacokinetics
Paracetamol is rapidly and almost completely absorbed from the gastrointestinal tract. Associated with plasma proteins by 15%. Paracetamol penetrates the blood-brain barrier. Less than 1% of the paracetamol dose taken by the nursing mother passes into breast milk. A therapeutically effective plasma concentration of paracetamol is achieved when administered at a dose of 10–15 mg / kg body weight. The half-life is 1-4 hours. Paracetamol is metabolized in the liver and excreted in the urine, mainly as glucuronides and sulfonated conjugates, less than 5% is excreted unchanged in the urine.
Indications
Pain syndrome of low and moderate intensity of various genesis (including headache, migraine, toothache, neuralgia, myalgia, algomenorrhea, pain with injuries, burns). Fever with infectious and inflammatory diseases.
Composition
Excipients: gelatin, potato starch, stearic acid, milk sugar (lactose).
Paracetamol is marketed under different brands and generic names, and comes in different dosage forms:
Brand name | Manufacturer | Country | Dosage form |
---|---|---|---|
Paracetamol | Tatkhimpharmpreparaty | Russia | pills |
Paracetamol | Pharmstandard | Russia | pills |
Children's Panadol | GlaxoSmithKline | UK | rectal suppositories |
Panadol | GlaxoSmithKline | UK | pills |
Efferalgan | UPSA SAS | France | rectal suppositories |
Paracetamol | Pharmstandard | Russia | suspension |
Paracetamol | Biochemist | Russia | rectal suppositories |
Paracetamol | PFK Obnovlenie | Russia | pills |
Paracetamol-Altfarm | Altfarm | Russia | rectal suppositories |
Perfalgan | Bristol-Myers Squibb | USA | solution |
Cefekon D | Nizhpharm | Russia | rectal suppositories |
Cefekon H | Nizhpharm | Russia | rectal suppositories |
Paracetamol | Synthesis AKOMP | Russia | syrup |
Panadol | GlaxoSmithKline | UK | suspension |
Efferalgan | UPSA SAS | France | effervescent pills |
Efferalgan | UPSA SAS | France | syrup |
No customer reviews for the moment.
Dosage and Administration
Inside or rectally, in adults and adolescents weighing more than 60 kg, they are used in a single dose of 500 mg, up to 4 times a day. The maximum duration of treatment is 5-7 days.
Maximum doses: single - 1 g, daily - 4 g.
Single doses for oral administration for children aged 6-12 years - 250-500 mg, 1-5 years - 120-250 mg, from 3 months to 1 year - 60-120 mg, up to 3 months - 10 mg / kg. Single doses for rectal use in children aged 6-12 years - 250-500 mg, 1-5 years - 125-250 mg.
The frequency of use is 4 times / day with an interval of at least 4 hours. The maximum duration of treatment is 3 days.
Maximum dose: 4 single doses per day.
Adverse reactions
In recommended doses, the drug is usually well tolerated. Paracetamol rarely causes side effects. Sometimes allergic reactions (skin rash, itching, hives, Quincke’s edema), exudative erythema multiforme (including Stevens-Johnson syndrome), toxic epidermal necrolysis (Lyell’s syndrome), dizziness, nausea, epigastric pain can be observed; anemia, thrombocytopenia, agranulocytosis; insomnia. With prolonged use in large doses - increases the likelihood of impaired liver and kidney function, as well as the hematopoietic system.
From the digestive system: nausea, epigastric pain, increased liver enzymes, hepatonecrosis. On the part of the endocrine system: hypoglycemia. If you experience unusual symptoms, you should consult a doctor.
Carefully: use with caution in benign hyperbilirubinemia (including Gilbert's syndrome), viral hepatitis, alcoholic liver damage, deficiency of glucose-6-phosphate dehydrogenase, alcoholism, pregnancy, lactation, in old age. The drug should not be taken simultaneously with other paracetamol-containing drugs.
Drug interactions
With simultaneous use with inducers of liver microsomal enzymes, agents with hepatotoxic effects, there is a risk of enhancing the hepatotoxic effects of paracetamol.
When applied simultaneously with anticoagulants, a slight or moderately pronounced increase in prothrombin time is possible.
With simultaneous use of anticholinergic agents may decrease the absorption of paracetamol.
With simultaneous use with oral contraceptives accelerated excretion of paracetamol from the body and may decrease its analgesic action.
When used simultaneously with uricosuric agents, their effectiveness is reduced.
With the simultaneous use of Activated charcoal decreases the bioavailability of paracetamol.
With simultaneous use with diazepam may decrease the excretion of diazepam.
There are reports of the possibility of enhancing the myelodepressive effect of zidovudine with simultaneous use with paracetamol. A case of severe toxic liver damage is described.
Cases of manifestations of toxic action of paracetamol with simultaneous use with isoniazid are described.
With simultaneous use with carbamazepine, phenytoin, phenobarbital, primidone, the effectiveness of paracetamol decreases, which is caused by an increase in its metabolism (glucuronization and oxidation processes) and excretion from the body. Cases of hepatotoxicity with simultaneous use of paracetamol and phenobarbital are described.
If Kolestiramine is used for a period of less than 1 hour after taking paracetamol, the absorption of the latter may be reduced.
With simultaneous use with lamotrigine moderately increases the elimination of lamotrigine from the body.
With simultaneous use with metoclopramide may increase the absorption of paracetamol and increase its concentration in the blood plasma.
With simultaneous use of probenecid, a decrease in paracetamol clearance is possible; with rifampicin, sulfinpyrazone - possible increase in clearance of paracetamol due to an increase in its metabolism in the liver.
With simultaneous use with ethinyl estradiol increases the absorption of paracetamol from the intestine.
Pregnancy and Lactation
Paracetamol penetrates the placental barrier. To date, no negative effects of paracetamol on the fetus in humans have been observed.
Paracetamol is excreted in breast milk: the content in milk is 0.04-0.23% of the dose taken by the mother.
If paracetamol is used during pregnancy and lactation (breastfeeding), the expected benefit of therapy for the mother and the potential risk to the fetus or baby should be carefully weighed.
In experimental studies, the embryotoxic, teratogenic and mutagenic effects of paracetamol have not been established.
Special instructions
It is used with caution in patients with impaired liver and kidney function, with benign hyperbilirubinemia, and in elderly patients.
With long-term use of paracetamol, control of the pattern of peripheral blood and the functional state of the liver is necessary.
It is used to treat premenstrual tension syndrome in combination with pamabrom (diuretic, xanthine derivative) and mepyramine (histamine H blocker1-receptors).
Overdosage
Signs of paracetamol overdose - nausea, vomiting, stomach pain, pale skin, anorexia. In a day or two, signs of liver damage are determined. In severe cases, liver failure and coma develops. A specific antidote for paracetamol poisoning is N-acetylcysteine.
Symptoms: pallor of the skin, anorexia, nausea, vomiting; hepatonecrosis (severity of necrosis is directly dependent on the degree of overdose). If you suspect an overdose, you should immediately seek medical help. The toxic effect of the drug in adults is possible after taking more than 10-15 g of paracetamol: an increase in the activity of liver transaminases, an increase in prothrombin time (12-48 hours after administration); A detailed clinical picture of liver damage occurs after 1-6 days. Rarely, liver dysfunction develops with lightning speed and may be complicated by renal failure (tubular necrosis).
Treatment: the victim should do a gastric lavage during the first 4 hours of poisoning, take the adsorbents (Activated charcoal) and consult a doctor, the introduction of SH donators and precursors of the synthesis of glutathione - methionine 8-9 hours after the overdose and N-acetylcysteine - after 12 h. The need for additional therapeutic measures (further introduction of methionine, IV the introduction of N-acetylcysteine) is determined depending on the concentration of paracetamol in the blood, as well as the time elapsed after its administration.
- Active ingredient: Paracetamol
Studies and clinical trials of Paracetamol (Click to expand)
- ROLE OF MACROPHAGES IN ACETAMINOPHEN (PARACETAMOL)-INDUCED HEPATOTOXICITY
- Oral Paracetamol Bioavailability in Rats Subjected to Experimental Spinal Cord Injury
- Pharmacokinetics of antipyrine, warfarin and paracetamol in the brushtail possum
- Antihepatotoxic activity of Swertia chirata on paracetamol and galactosamine induced hepatotoxicity in rats
- The effect of ultrasonic vibration on the compaction characteristics of paracetamol
- Protective effect of leaf extract of Ficus hispida Linn. against paracetamol-induced hepatotoxicity in rats
- Improving Mechanical Properties of Crystalline Solids by Cocrystal Formation: New Compressible Forms of Paracetamol
- Crystal growth rates of paracetamol in mixtures of water + acetone + toluene
- Agglomeration and adhesion free energy of paracetamol crystals in organic solvents
- Quantitative Bestimmung von Paracetamol im Blutserum durch HPLC mit Direktinjektion
- HPLC-Bestimmung von Paracetamol im Serum unter Verwendung der elektrochemischen Detektion
- Effect of Guaiazulene on Some Cytochrome P450 Activities. Implication in the Metabolic Activation and Hepatotoxicity of Paracetamol
- Diclofenac, paracetamol, and vidarabine removal during plasma exchange in polyarteritis nodosa patients
- Influence of probenecid and paracetamol (acetaminophen) on zidovudine glucuronidation in human liver in vitro
- Importance of entero-salivary recirculation in paracetamol pharmacokinetics
- Development of the second-order derivative UV spectrophotometric method for direct determination of paracetamol in urine intended for biopharmaceutical characterisation of drug products
- Determination of paracetamol (acetaminophen) in blood and plasma using high performance liquid chromatography with dual electrode coulometric quantification in the redox mode
- Analysis of the glutathione conjugate of paracetamol in human liver microsomal fraction by liquid chromatography mass spectrometry
- A method for the estimation of acetanilide, paracetamol and phenacetin in plasma and urine using mass fragmentography
- An assay for paracetamol, produced by the O-deethylation of phenacetin in vitro, using gas chromatography/electron capture negative ion chemical ionization mass spectrometry
- Choice of optimum pharmacokinetic model of orally administered paracetamol
- ChemInform Abstract: An Oxidatively Coupled Dimer of Paracetamol.
- Synthesis and Microbial Activity of New 1,4-Benzothiazines Bearing Paracetamol Moiety.
- Dual Fluorescence and Biological Evaluation of Paracetamol Ethers from 4-Bromomethylcoumarins.